Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Clin Immunol. 2018 Sep 25;38(7):787–793. doi: 10.1007/s10875-018-0548-1

Table 1.

Genetic and clinical manifestations of patients with complete IL-12Rβ1 deficiency

Case Age of
investigation
Age of
onset
Candida
infection
Mycobacterial
osteomyelitis
Treatment Outcome Mutation
P1 7 years 4 months: BCG-itis + INH, RIF, CLM, ETB, INF-γ alive c.1172delC/1172delC
P2 5 years 4 months: BCG-itis + RIF,CLM,INH, IFN-γ alive c.1791+2T>G/1791+2T>G
P3 26 years 2 years: BCG-itis + RIF, CLM,INH alive c.1791+2T>G/1791+2T>G
P4 3 months 3 months: BCG-itis INH, CLM,RIF dead c.962C>A /962C>A

Isoniazid (INH), Rifampicin (RIF), Clindamycin (CLM), Ethambutol (ETB)